GEN-PROBE INC GPRO (NASDAQ) $ 40.65 Change: -0.73 -1.8% | Volume: 1,126,602
Sponsored by Click here!

GEN- PROBE INC

Company Information

Ticker Symbol: GPRO
Exchange: NASD
Contact Info: 10210 Genetic Center Drive San Diego CA 92121-4362 858 410-8000
CEO/President: Henry L. Nordhoff
Industry: Medical - Biomedical / Standard Industry Code: 3841
Description: Gen-Probe Inc. is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing (NAT) products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals for more than 40 products that detect a wide variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections.

Share Information

Shares Outstanding: 54,210 (000) Market Value: 2,323,610 ($000)
Percentage of Inst.Shareholders: 93.17% Number of Inst.Shareholders: 2.00%
Last Quarter Sales: 121.18 ($Mil.) Last Quarter Net Income: 29.08 ($Mil.)
Last Quarter EPS: 0.53 P/E Ratio: 22
Most Recent Earnings: 0.53 on 10/30/08 Earnings Per Share: 1.93
Most Recent Split: 2-1 on 10/01/03 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41